American Portfolios Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $689 | Hold |
13
| – | – | ﹤0.01% | 3335 |
|
|
2022
Q2 | $714 | Hold |
13
| – | – | ﹤0.01% | 3342 |
|
|
2022
Q1 | $900 | Hold |
13
| – | – | ﹤0.01% | 3391 |
|
|
2021
Q4 | $1.24K | Hold |
13
| – | – | ﹤0.01% | 3287 |
|
|
2021
Q3 | $1.12K | Hold |
13
| – | – | ﹤0.01% | 3271 |
|
|
2021
Q2 | $1.05K | Hold |
13
| – | – | ﹤0.01% | 3252 |
|
|
2021
Q1 | $1.22K | Hold |
13
| – | – | ﹤0.01% | 3097 |
|
|
2020
Q4 | $796 | Sell |
13
-104
| -89% | -$6.37K | ﹤0.01% | 2863 |
|
|
2020
Q3 | $6.96K | Hold |
117
| – | – | ﹤0.01% | 2138 |
|
|
2020
Q2 | $8.17K | Hold |
117
| – | – | ﹤0.01% | 2009 |
|
|
2020
Q1 | $5.31K | Buy |
117
+18
| +18% | +$817 | ﹤0.01% | 2062 |
|
|
2019
Q4 | $6.47K | Hold |
99
| – | – | ﹤0.01% | 2169 |
|
|
2019
Q3 | $6.17K | Buy |
99
+19
| +24% | +$1.18K | ﹤0.01% | 2114 |
|
|
2019
Q2 | $5.71K | Sell |
80
-26
| -25% | -$1.86K | ﹤0.01% | 2133 |
|
|
2019
Q1 | $8.3K | Sell |
106
-30
| -22% | -$2.35K | ﹤0.01% | 1901 |
|
|
2018
Q4 | $11.5K | Buy |
136
+67
| +97% | +$5.68K | ﹤0.01% | 1570 |
|
|
2018
Q3 | $11.8K | Sell |
69
-24
| -26% | -$4.11K | ﹤0.01% | 1696 |
|
|
2018
Q2 | $12K | Hold |
93
| – | – | ﹤0.01% | 1652 |
|
|
2018
Q1 | $9.58K | Hold |
93
| – | – | ﹤0.01% | 1648 |
|
|
2017
Q4 | $7.94K | Buy |
+93
| New | +$7.94K | ﹤0.01% | 1643 |
|